Movano is in the development-stage and is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medical and consumer devices. Co.'s solutions are being developed to provide vital health information, including heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, calories as well as glucose and blood pressure data, in a variety of form factors. Co.'s initial commercial product in development is the Evie Ring, which is a wearable designed specifically for women. Co. is also developing a small proprietary System-on-a-Chip designed specifically for blood pressure or continuous glucose monitoring systems. We show 14 historical shares outstanding datapoints in our coverage of MOVE's shares outstanding history.
Understanding the changing numbers of MOVE shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MOVE versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MOVE by allowing them to research MOVE shares outstanding history
as well as any other stock in our coverage universe. |
Free MOVE Email Alerts:
Video: Shares Outstanding Importance
